Evidence map›Paper›PMID 26238292›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2015

Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis.

Shervin Assassi, William R Swindell, Minghua Wu, Filemon D Tan, Dinesh Khanna, Daniel E Furst, Donald P Tashkin, Richard R Jahan-Tigh, Maureen D Mayes, Johann E Gudjonsson and 1 more

Open access · greenAbstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 2 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 2 syntheses or guidelines pooled it, 150 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Unraveling the role of MiR-181 in skin fibrosis pathogenesis by targeting NUDT21.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 5 countries.

Shervin AssassiUniversity of Texas Health Science Center at Houston.
William R SwindellUniversity of Michigan, Ann Arbor.
Minghua WuUniversity of Texas Health Science Center at Houston.
Filemon D TanUniversity of Texas Health Science Center at Houston.
Dinesh KhannaUniversity of Michigan, Ann Arbor.
Daniel E FurstUniversity of California, Los Angeles.
Donald P TashkinUniversity of California, Los Angeles.
Richard R Jahan-TighUniversity of Texas Health Science Center at Houston.
Maureen D MayesUniversity of Texas Health Science Center at Houston.
Johann E GudjonssonUniversity of Michigan, Ann Arbor.
Jeffrey T ChangUniversity of Texas Health Science Center at Houston.
University of Michigan–Ann Arbor · USBristol-Myers Squibb (Germany) · DEGlaxoSmithKline (India) · INMerck (Germany) · DENovartis (Switzerland) · CHRoche (Switzerland) · CHUniversity of California, Los Angeles · US

Funding

Center for Clinical and Translational Sciences (CCTS)UL1TR000371 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$13.4M
CTSA: K12 COMPONENTKL2RR024149 · NCRR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2006 to 2011
$6.7M
Role of the Psoriasis Associated IL23R Risk Variants on Th17 Biology and FunctionK08AR060802 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GUDJONSSON, JOHANN ELI · 2011 to 2015
$636k
Molecular Markers for Progression of Pulmonary Fibrosis in Systemic SclerosisK23AR061436 · NIAMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ASSASSI, SHERVIN · 2011 to 2014
$494k
NCATS NIH HHS UL1 TR000371NCATS NIH HHS UL1-TR-000371NCRR NIH HHS KL2 RR024149NCRR NIH HHS KL2-RR-024149NIAMS NIH HHS K08 AR060802NIAMS NIH HHS K08-AR-060802NIAMS NIH HHS K23 AR061436NIAMS NIH HHS K23-AR-061436
6 · The paper itself

Abstract

objectiveTo examine the heterogeneity of global transcriptome patterns in systemic sclerosis (SSc) skin in a large sample of patients with SSc and control subjects.

methodsSkin biopsy specimens obtained from 61 patients enrolled in the Genetics versus Environment in Scleroderma Outcome Study (GENISOS) cohort and 36 unaffected control subjects with a similar demographic background were examined by Illumina HumanHT-12 bead arrays. Followup experiments using quantitative polymerase chain reaction and immunohistochemical analysis were also performed.

resultsWe identified 2,754 differentially expressed transcripts in SSc patients compared with controls. Clustering analysis revealed 2 prominent transcriptomes in SSc patients: the keratin and fibroinflammatory signatures. Higher keratin transcript scores were associated with shorter disease duration and interstitial lung disease, while higher fibroinflammatory scores were associated with diffuse cutaneous involvement, a higher skin score at the biopsy site, and a higher modified Rodnan skin thickness score. A subgroup of patients with significantly longer disease duration had a normal-like transcript pattern. Analysis of cell type-specific signature scores revealed remarkable heterogeneity across patients. Significantly higher scores were calculated for fibroblasts (72% of patients), microvascular cells (61%), macrophages (54%), and dendritic cells (DCs) (49%). The majority of samples with significantly higher fibroblast scores (35 of 44 [80%]) had significantly increased macrophage and/or DC scores. Further analysis and immunohistochemical staining indicated that the keratin signature was not a general marker of keratinocyte activation but was in fact associated with an activation pattern in hair and adnexal structures.

conclusionProminent fibroinflammatory and keratin signatures are present in SSc skin. Expression profiles of SSc skin show significant heterogeneity, and this finding might be useful for stratifying patients for targeted therapies or predicting the response to immunosuppression.

Indexed as

Gene ExpressionAdultAgedFemaleFibroblastsHumansMaleMiddle AgedScleroderma, SystemicSkinTranscriptome

Identifiers

PMID26238292
PMCPMC5394431
OpenAlexW2164368832

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.